NEWTOWN | Jotup

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

Retrieved on:

화요일, 5월 7, 2024

HSDT, Sale, Prospectus, Suite, Form, Common stock, Venture round, Equity capital markets, Capital Group Companies, Telephone, Security (finance)

The public offering price per share of Common Stock and accompanying Series A and Series B warrants is $2.25 and the public offering price per Pre-Funded Warrant and accompanying Series A and Series B warrant is $2.249, resulting in gross proceeds of approximately $6.4 million before deducting the placement agent's fees and other estimated offering expenses.

Key Points:

The public offering price per share of Common Stock and accompanying Series A and Series B warrants is $2.25 and the public offering price per Pre-Funded Warrant and accompanying Series A and Series B warrant is $2.249, resulting in gross proceeds of approximately $6.4 million before deducting the placement agent's fees and other estimated offering expenses.
The offering is expected to close on or about May 9, 2024, subject to customary closing conditions.
The Company intends to use the net proceeds from this offering for funding operations, working capital and other general corporate purposes.
Craig-Hallum Capital Group LLC is acting as the sole placement agent for the offering.

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

Retrieved on:

화요일, 5월 7, 2024

Volunteering, Mortality, Cancer, Hope, Safety, SARS-CoV-2, Pharmacokinetics, CDC, COVID19, Ageing, Infection, Pharmaceutical industry

NEWTOWN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical company developing oral small molecules for respiratory viral diseases and cancer, today announced that it completed dosing in the first cohort of the first-in-human Phase 1 study to evaluate travatrelvir (TRX01), an orally-available protease inhibitor, in development for treatment of COVID19. There have been no safety observations reported.

Key Points:

“COVID-19 remains a significant global health concern, with SARS-CoV-2 infections posing a leading cause of mortality, especially among individuals aged 65 and above,” stated Werner Cautreels, Ph.D., Chief Executive Officer of Traws Pharma.
“Our mission at Traws is to develop novel agents to treat respiratory viral diseases.
We expect to report topline data from the Phase 1 study in H2 2024, followed by the initiation of an international Phase 2 safety and efficacy study."
Robert R. Redfield, M.D., Chief Medical Officer of Traws Pharma and former director of the US Centers for Disease Control (CDC) added, “Travatrelvir has an exciting and unique profile.

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)

Retrieved on:

월요일, 5월 6, 2024

HSDT, CMS, Stroke, Pons, Public, Medicare, Helios, HCPCS, Health insurance

NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (CMS) posted proposed Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule payment rates for the PoNS Controller and Mouthpiece to be discussed at the bi-annual Healthcare Common Procedure Coding System (HCPCS) Public Meeting, scheduled for May 29, 2024.

Key Points:

For the PoNS Mouthpiece (HCPCS code A4594), CMS based pricing on the cash pay price of $4,500, resulting in a total capped payment of $3,075.53.
For the PoNS Controller (HCPCS Code A4593), CMS preliminarily set pricing by mapping reimbursement to existing code E0745, (Neuromuscular stimulator, electronic shock unit), resulting in a total capped fee of $1,206.53.
“CMS’s preliminary determination of reimbursement for both the PoNS Controller and Mouthpiece is a significant win for Helius,” stated Helius’ President and Chief Executive Officer, Dane Andreeff.
The Company cannot provide any assurance that these rates will be finalized and adopted in their current amounts, or at all.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By The Continuum Health Alliance, LLC Data Breach

Retrieved on:

목요일, 5월 2, 2024

HERE, LLP, Privacy

NEWTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Continuum Health Alliance, LLC. Continuum Health learned of suspicious activity on or about February 26, 2024. To join this case, go HERE .

Key Points:

NEWTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Continuum Health Alliance, LLC. Continuum Health learned of suspicious activity on or about February 26, 2024. To join this case, go HERE .

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Retrieved on:

수요일, 4월 24, 2024

NEWTOWN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the expansion of its clinical development program for the broadening of the labeling of its marketed PoNS device to include patients recovering from stroke with the participation of Shepherd Center, under the direction of Michael Yochelson, M.D., MBA, FAAN, FAAPMR, Chief Medical Officer. Participating to the Company-sponsored single-arm study, Shepherd Center joins Brooks Rehabilitation as a third clinical site to the overall registrational program. As one of the nation’s top neurorehabilitation hospitals, Shepherd Center is known for its innovation, patient outcomes exceeding the national average, and expertise in providing world-class clinical care for people experiencing the most complex conditions, including stroke, spinal cord and brain injuries, multi-trauma, traumatic amputations, multiple sclerosis, and pain.

Key Points:

Participating to the Company-sponsored single-arm study, Shepherd Center joins Brooks Rehabilitation as a third clinical site to the overall registrational program.
“Shepherd Center has been a valuable partner to Helius for almost two years.
We are delighted Dr. Yochelson has agreed to contribute to the implementation of our stroke registrational program and undertake the study at Shepherd Center,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer.
“Shepherd Center’s earlier involvement with the MS program is a testament to the strength of our clinical program.

INVESTIGATION ALERT: Edelson Lechtzin LLP is Investigating Globe Life Inc. (NYSE: GL) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Retrieved on:

목요일, 4월 18, 2024

LLP, Research, Life insurance

NEWTOWN, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Globe Life Inc. (NYSE: GL) resulting from allegations of providing potentially misleading business information to the investing public.

Key Points:

NEWTOWN, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Globe Life Inc. (NYSE: GL) resulting from allegations of providing potentially misleading business information to the investing public.
If you have non-public information that could assist in the Globe Life Investigation or if you are a Globe Life investor who suffered a loss and would like to learn more, you can provide your information HERE .
THE ALLEGED WRONGDOING: Globe Life, the parent company of American Income Life, is currently facing allegations of insurance fraud.
A report published by Fuzzy Panda Research on April 11, 2024, claimed there was widespread fraud at the company.

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Group Health Cooperative of South Central Wisconsin Customer Whose Personal Data May Have Been Compromised in the Recent Data Breach

Retrieved on:

수요일, 4월 10, 2024

Social Security, Address, Computer, Social, HERE, LLP, Identity theft, Privacy, Cryptocurrency

NEWTOWN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Group Health Cooperative of South Central Wisconsin (“GHC-SCW”).

Key Points:

NEWTOWN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Group Health Cooperative of South Central Wisconsin (“GHC-SCW”).
While the ransomware attack was not successful, GHC-SCW has confirmed that the hackers were able to access confidential customer data.
This data breach may have exposed sensitive personal data, including your name, date of birth, address, phone number, email address, Medicare/Medicaid numbers, and Social Security number.
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of GHC-SCW customers who may have had their sensitive personal data compromised by the GHC-SCW data breach.

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Customers Whose Personal Data May Have Been Compromised by the Greylock McKinnon Associates, Inc. Data Breach

Retrieved on:

화요일, 4월 9, 2024

Name, Social Security, Medicare, Privacy, Social, HERE, LLP, Private investigator

NEWTOWN, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Greylock McKinnon Associates, Inc. Greylock McKinnon learned of suspicious activity on or about May 30, 2023.

Key Points:

NEWTOWN, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Greylock McKinnon Associates, Inc. Greylock McKinnon learned of suspicious activity on or about May 30, 2023.
On or about May 30, 2023, Greylock McKinnon detected unusual activity on its internal network and took action to address the situation, including consulting with third-party cybersecurity experts about the incident.
How can I protect my personal data?
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the Greylock McKinnon data breach.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By The City of Hope Data Breach

Retrieved on:

금요일, 4월 5, 2024

Social Security, Privacy, City, Social, Computer, HERE, LLP

NEWTOWN, Pa., April 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by City of Hope, a cancer hospital and research center.

Key Points:

NEWTOWN, Pa., April 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by City of Hope, a cancer hospital and research center.
City of Hope learned of suspicious activity on or about October 13, 2023.
On or about October 13, 2023, City of Hope detected suspicious activity on its computer systems and took immediate action to contain it.
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the City of Hope data breach.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By The On Q Financial, LLC Data Breach

Retrieved on:

금요일, 4월 5, 2024

Social Security, Privacy, Social, ConnectWise Control, HERE, LLP, Software, Cryptocurrency

NEWTOWN, Pa., April 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by On Q Financial, LLC.

Key Points:

NEWTOWN, Pa., April 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by On Q Financial, LLC.
On Q Financial learned of suspicious activity on or about February 20, 2024.
On or about February 20, 2024, On Q Financial received a notification from a third-party software vendor regarding a vulnerability in its product, ScreenConnect, which On Q Financial used for remote computer access.
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the On Q Financial data breach.